ARCHIVES

Ramucirumab Improves Overall Survival, Progression-Free Survival in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

ACS announces 415 New Awards

August 31, 1979

NCI, Six Centers Begin Feasibility Study Of Spiral CT For Lung Cancer Screening.

September 8, 2000

Obituary: Joseph Burchenal, 93, A Leader In Cancer Drug Development at MSKCC.

March 17, 2006

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

Smoking Conference Established Priorities

January 15, 1982

ONS Adopts Position Statement On Rehabilitation

May 5, 1989